Latest Breaking News On - Presentation number - Page 1 : vimarsana.com

Kinomica Ltd : Kinomica, King s College London and King s College Hospital NHS Foundation Trust to Present Research Abstract at the 2024 ASCO Annual Meeting

Investigators will present study highlighting a phosphoproteomic diagnostic for patient stratification of first line systemic hepatocellular carcinoma therapy LONDON, May 28, 2024 /PRNewswire/

United kingdomUnited statesCity ofDebashis sarker mbchPrnewswire kinomica ltdKing health partnersConsultant medical oncologist at king college hospitalKing college hospital denmark hillAmerican society of clinical oncologyAcademic health science centrePrincess royal university hospitalKing college londonKing college hospitalCollege londonCollege hospitalAmerican society

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May

United statesSan antonioUnited kingdomJustin moserJordi rodon ahnertKyriakos papadopoulosJosefin beate holzHonorhealth research instituteAmerican society of clinical oncologyTherapeutics ltdStorm therapeutics ltdIp groupUtokyo innovation platform co ltdFast track initiativeJustin moser at honorhealth research instituteSeroba life sciences

NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June

/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,.

United statesUnited kingdomMichael feighAhyoung kimMichael millerYuna chaeSu jin leeHoon jungHenrikb hansenMonika lewinskaSujin leeShun jungMi kyung kimMarshallh woodworthNeurobo pharmaceuticalsAmerican diabetes association

EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING

EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJulie schwartzbardMarwann sabbaghMichael irizarryDavidc weismanAd cooperative studyPrnewswire eisai incAmyloid following lecanemab administration in patientsClinical research at eisai incAmerican academy of neurologyEisai incEuropean unionAmerican academyDeputy chief clinical officerSenior vice presidentClinical research

Genprex (GNPX) Collaborators Report Positive Preclinical Data on the Use of Reqorsa and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers

Genprex (GNPX) Collaborators Report Positive Preclinical Data on the Use of Reqorsa and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRodney varnerAmerican association for cancer researchGenprex incEpigenetic influences on cancer developmentImmunogene therapyDelivery systemCancer researchAnnual meetingChief executive officerNon small cell lung carcinomaCellular biologyPoster sectionBoard numberPresentation number